Bill bans corporate ownership of medical practices, exempts hospitals.

What it does

This bill prohibits non-physician-owned corporations from owning medical practices or employing physicians, and bans non-compete agreements, non-disclosure agreements, and employer interference with clinical judgment. It also restricts management services organizations (MSOs) from controlling medical practices, requiring physician ownership and control of medical practices and limiting MSO involvement in hiring, billing, clinical standards, and operational decisions. Physicians and advanced practice providers benefit by retaining autonomy and ownership; corporate healthcare operators and MSOs lose the ability to own or control medical practices.

Why we flagged it

The bill's core mechanism is a structural prohibition on non-physician-owned corporate control of medical practices, combined with protections for physician autonomy and contractual freedom. This is fundamentally a deconsolidation and ownership-restoration measure, not a consumer protection or public-health bill, though it frames itself as protecting physicians.

What the text implies

• The bill may significantly reduce healthcare consolidation, which could fragment care delivery and eliminate economies of scale that lower administrative costs and improve care coordination—effects that may ultimately harm patient access and affordability.
• Hospitals and hospital-affiliated clinics are explicitly exempted, creating a two-tier system where hospital-employed physicians remain subject to corporate control while independent practices do not—potentially accelerating physician employment by hospitals rather than slowing consolidation.
• The 1-year effective date gives existing corporate-owned practices time to restructure, but may force rapid divestment or reorganization, creating operational disruption and potential job losses in healthcare administration.
• The bill grants the FTC broad rulemaking authority to define what constitutes 'interference with clinical judgment,' creating regulatory uncertainty and potential for expansive enforcement that could affect legitimate administrative and quality-control functions.
• Non-compete bans may increase physician mobility but could also reduce practice investment in training and development if physicians can easily leave, and may increase costs for practices competing for talent in tight labor markets.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Physicians and advanced practice providers gain significant protections: ownership control, clinical autonomy, freedom from non-competes, and protection from employer retaliation. However, the bill may reduce healthcare consolidation benefits (economies of scale, integrated care networks, administrative efficiency) that can lower costs and improve coordination for patients, and may limit access to capital and management expertise that smaller practices rely on. The net effect on ordinary patient

Who stands to gain

• Physicians and advanced practice providers (ownership retention, non-compete freedom, clinical auton
• Smaller independent medical practices (protected from corporate acquisition and MSO control)

Named in the bill

Federal Trade Commission (FTC), Management Services Organizations (MSOs), Physicians, Advanced Practice Providers (physician assistants, nurse practitioners), Hospitals, Hospital-affiliated clinics, Critical Access Hospitals, Rural Emergency Hospitals, Non-profit health care providers, Secretary of Health and Human Services

Where it stands

10 cosponsors: 10 Democrats.

• Sep 16, 2026 — Introduced · Congress.gov: “Introduced in House”
• Sep 16, 2026 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.